Literature DB >> 9420789

Reversible ischemia in severe stress technetium 99m-labeled sestamibi perfusion defects assessed from gated single-photon emission computed tomographic polar map Fourier analysis.

K A Williams1, L A Taillon.   

Abstract

BACKGROUND: Detection of reversible ischemia and regional viability by inference from the presence of preserved resting myocardial thickening on dynamic electrocardiographic-gated tomographic (GSPECT) images obtained after stress injection could potentially obviate the need for a separate resting injection. This would decrease the cost, effort, duration, and radiation exposure of diagnostic myocardial perfusion imaging. The aim of this study was to determine whether functional images derived from GSPECT stress myocardial perfusion images, which represent indices of regional wall thickening, could predict the pattern of reversibility of perfusion defects in myocardial segments with severe perfusion defects on stress 99mTc-labeled sestamibi (99mTc-sestamibi) images. METHODS AND
RESULTS: Reversible ischemia in myocardial segments with severe hypoperfusion (< or = 50% of normal activity) on stress 99mTc-sestamibi images was assessed with GSPECT indexes of myocardial thickening, as reflected by an increase in regional count density during systole. GSPECT bullseye plots were generated for each of eight frames acquired after stress 99mTc-sestamibi injection in 44 patients with coronary artery disease and at least one severe perfusion defect on summed (ungated) SPECT images. With first harmonic Fourier amplitude (AMP) and AMP/perfusion ratio (APR) images, regional myocardial systolic thickening was assessed according to a nine-segment model as absent, markedly reduced, mildly reduced, or normal thickening. These data were compared on a regional basis with defect reversibility determined with resting sestamibi images. Of 124 severe stress defects, 32 showed absent, 53 minimal, 35 partial, and four complete reversibility on resting images. AMP and APR scores had 75% and 82% agreement on the presence or absence of reversibility on resting images, respectively (both p < or = 0.00005), and both had significant agreement (p = 0.0072 and p < or = 0.00005, respectively) with resting reversibility grades by kappa analysis. AMP correctly identified 83% of the defects that were reversible on resting images, whereas the APR identified 96% (p = 0.0014 for sensitivity of APR vs AMP). On analysis of the triad of segment scores, the AMP slightly underestimated the degree of resting reversibility (p = 0.0002), whereas APR images indicated more reversibility than did resting images (p < or = 0.00005). AMP and APR indicated a greater degree of reversibility than did resting images in at least one myocardial segment in 13 (30%) and 27 (61%) of the 44 patients, respectively.
CONCLUSIONS: The presence and degree of reversible ischemia in severe stress sestamibi perfusion defects seen on resting images can be detected reliably by the pattern of regional myocardial thickening demonstrated by Fourier analysis of GSPECT polar maps. When indexed for degree of perfusion, the APR images predict a greater degree of reversibility than do resting images.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9420789     DOI: 10.1016/s1071-3581(05)80056-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  20 in total

1.  Quantitative phase analysis of myocardial wall thickening by technetium-99m 2-methoxy-isobutyl-isonitrile SPECT.

Authors:  T Takeda; H Toyama; N Ishikawa; M Satoh; T Masuoka; R Ajisaka; K Iida; W Jin; Y Sugishita; Y Itai
Journal:  Ann Nucl Med       Date:  1992-05       Impact factor: 2.668

2.  [Myocardial viability in old myocardial infarction as evaluated by T1-201 SPECT and two-dimensional echocardiography].

Authors:  R Tsukahara
Journal:  J Cardiol       Date:  1991       Impact factor: 3.159

3.  Assessment of systolic thickening with thallium-201 ECG-gated single-photon emission computed tomography: a parameter for local left ventricular function.

Authors:  T Mochizuki; K Murase; Y Fujiwara; S Tanada; K Hamamoto; W N Tauxe
Journal:  J Nucl Med       Date:  1991-08       Impact factor: 10.057

4.  The hibernating myocardium.

Authors:  S H Rahimtoola
Journal:  Am Heart J       Date:  1989-01       Impact factor: 4.749

5.  Detection of viable myocardium in segments with fixed defects on thallium-201 scintigraphy: usefulness of magnetic resonance imaging early after acute myocardial infarction.

Authors:  D L Johnston; V K Gupta; R E Wendt; J J Mahmarian; M S Verani
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

6.  Left ventricular ejection fraction assessed from gated technetium-99m-sestamibi SPECT.

Authors:  E G DePuey; K Nichols; C Dobrinsky
Journal:  J Nucl Med       Date:  1993-11       Impact factor: 10.057

7.  Does the myocardium become "stunned" after episodes of angina at rest, angina on effort, and coronary angioplasty?

Authors:  P Marzullo; O Parodi; G Sambuceti; C Marcassa; A Gimelli; M Bartoli; D Neglia; A L'Abbate
Journal:  Am J Cardiol       Date:  1993-05-01       Impact factor: 2.778

8.  Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201Tl in patients with chronic coronary artery disease and left ventricular dysfunction.

Authors:  P Perrone-Filardi; S L Bacharach; V Dilsizian; S Maurea; J A Frank; R O Bonow
Journal:  Circulation       Date:  1992-10       Impact factor: 29.690

9.  Determining the accuracy of calculating systolic wall thickening using a fast Fourier transform approximation: a simulation study based on canine and patient data.

Authors:  C D Cooke; E V Garcia; S J Cullom; T L Faber; R I Pettigrew
Journal:  J Nucl Med       Date:  1994-07       Impact factor: 10.057

10.  Rate of left ventricular functional recovery by radionuclide angiography after exercise in coronary artery disease.

Authors:  R M Schneider; W S Weintraub; L W Klein; P A Seelaus; J B Agarwal; R H Helfant
Journal:  Am J Cardiol       Date:  1986-04-15       Impact factor: 2.778

View more
  7 in total

1.  Combined analysis of resting regional wall thickening and stress perfusion with electrocardiographic-gated technetium 99m-labeled sestamibi single-photon emission computed tomography: prediction of stress defect reversibility.

Authors:  H J Snapper; N L Shea; M A Konstam; E Oates; J E Udelson
Journal:  J Nucl Cardiol       Date:  1997 Jan-Feb       Impact factor: 5.952

Review 2.  Dynamic single photon emission computed tomography--basic principles and cardiac applications.

Authors:  Grant T Gullberg; Bryan W Reutter; Arkadiusz Sitek; Jonathan S Maltz; Thomas F Budinger
Journal:  Phys Med Biol       Date:  2010-09-22       Impact factor: 3.609

3.  A historical perspective on measurement of ventricular function with scintigraphic techniques: Part II--Ventricular function with gated techniques for blood pool and perfusion imaging.

Authors:  Kim A Williams
Journal:  J Nucl Cardiol       Date:  2005 Mar-Apr       Impact factor: 5.952

4.  Gated SPECT imaging: increasing the armamentarium of nuclear cardiology.

Authors:  G V Heller
Journal:  J Nucl Cardiol       Date:  1998 Jul-Aug       Impact factor: 5.952

5.  Overestimation of postischemic myocardial stunning on gated SPECT imaging: correlation with echocardiography.

Authors:  R Parker Ward; Ethan L Gundeck; Roberto M Lang; Kirk T Spencer; Kim A Williams
Journal:  J Nucl Cardiol       Date:  2006-07       Impact factor: 5.952

6.  Single Tc99m Sestamibi injection, double acquisition gated SPECT after stress and during low-dose dobutamine infusion: a new suggested protocol for evaluation of myocardial perfusion.

Authors:  Babak Fallahi; Davood Beiki; Ali Gholamrezanezhad; Babak Mahmoudian; Kianoush Ansari Gilani; Mohammad Eftekhari; Armaghan Fard-Esfahani; Zhila Mohseni; Mohsen Saghari
Journal:  Int J Cardiovasc Imaging       Date:  2008-06-18       Impact factor: 2.357

7.  Do patient data ever exceed the partial volume limit in gated SPECT studies?

Authors:  K Nichols; E G DePuey; M I Friedman; A Rozanski
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.